The present invention is directed to novel quinoline derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders related to ion channels such as potassium channels.
本发明涉及新型
喹啉衍
生物,包含它们的药物组合物以及它们在治疗与离子通道有关的疾病,如
钾通道相关的疾病中的应用。